Showing results (41-50 of 71) with videos related to
Sort By:
Pageof 8
Asian Pacific Journal of Cancer Prevention : APJCP|October 27, 2012
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical OncologyMehmet Kucukoner, Abdurrahman Isikdogan, Sebnem Yaman, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 25, 2014
Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in TurkeyMehmet Kucukoner, Mehmet Ali Kaplan, Ali Inal, et al.Asian Pacific Journal of Cancer Prevention : APJCP|December 19, 2012
Gemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerMeltem Baykara, Ugur Coskun, Veli Berk, et al.Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2012
Long term survivors with metastatic pancreatic cancer treated with gemcitabine alone or plus cisplatin: a retrospective analysis of an Anatolian Society of Medical Oncology multicenter studyAli Inal, Aydin Ciltas, Ramazan Yildiz, et al.Medical Oncology (Northwood, London, England)|June 11, 2013
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patientsAyse Durnali, Necati Alkis, Sengul Cangur, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|June 12, 2020
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre studyZeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 14, 2020
Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational studyMustafa Benekli, Mahmut Gumus, Metin Ozkan, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 2, 2019
Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre studyZeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli, et al.Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Trastuzumab-based Retreatment after Lapatinib in Heavily Pretreated HER2 Positive Metastatic Breast Cancer: an Anatolian Society of Medical Oncology StudyDogan Uncu, Ibrahim Vedat Bayoglu, Ulku Yalcintas Arslan, et al.Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from TurkeyBurcin Budakoglu, Kadri Altundag, Sercan Aksoy, et al.Pageof 8